<DOC>
	<DOCNO>NCT01185301</DOCNO>
	<brief_summary>The purpose study determine effect different dos methotrexate ( MTX ) take adalimumab subject early rheumatoid arthritis ( RA ) .</brief_summary>
	<brief_title>Study Determine Effects Different Doses Methotrexate ( MTX ) When Taken With Adalimumab Subjects With Early Rheumatoid Arthritis ( RA )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Male female subject least 18 year age Subject diagnosis Rheumatoid Arthritis ( RA ) define either 1987revised American College Rheumatology ( ACR ) classification criterion new ACR/ European League Against Rheumatism ( EULAR ) diagnostic criterion RA 2010 disease duration less 1 year diagnosis license health care provider Subject must meet following criterion : 1 . Disease Activity Score Creactive Protein ( DAS28 [ CRP ] ) ≥ 3.2 ( Baseline visit ) 2 . At least 6 swollen joint 66 assess ( Screening Baseline visit ) 3 . At least 8 tender joint 68 assess ( Screening Baseline visit ) 4 . Creactive protein ( CRP ) ≥ 1.5 mg/dL ( Screening visit ) , erythrocyte sedimentation rate ( ESR ) ≥ 28 mm/1h ( Screening Baseline visit ) 5 . Fulfill least one follow three criterion : Rheumatoid Factor ( RF ) positive , least 1 bony erosion , anticyclic citrullinated peptide ( antiCCP ) antibody positive Subject judge good health determine Principal Investigator base upon result medical history , laboratory profile , physical examination , chest xray ( CXR ) , 12lead electrocardiogram ( ECG ) perform Screening Subject previous exposure systemic biologic therapy include adalimumab Subject previously treat great 1 disease modify antirheumatic drug ( DMARDs ) methotrexate ( MTX ) Subject undergone joint surgery within precede two month ( joint assess within study ) Subject chronic arthritis diagnose age 17 year History invasive infection ( e.g. , listeriosis histoplasmosis ) , chronic active Hepatitis C infection , human immunodeficiency virus ( HIV ) infection , immunodeficiency syndrome , chronic recur infection active tuberculosis ( TB ) Hepatitis B virus : hepatitis B surface antigen ( HBs Ag ) positive ( + ) detect sensitivity hepatitis B virus DNA ( HBV DNA ) polymerase chain reaction ( PCR ) qualitative test Infection ( ) require treatment intravenous ( IV ) antiinfectives within 30 day prior Baseline Visit oral antiinfectives within 14 day prior Baseline visit Female subject pregnant breastfeeding consider become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Arthritis</keyword>
	<keyword>Erosion</keyword>
	<keyword>Humira</keyword>
	<keyword>Adalimumab</keyword>
	<keyword>Injection</keyword>
	<keyword>Rheumatoid</keyword>
	<keyword>Methotrexate</keyword>
</DOC>